• Blog
  • In-Vitro Toxicology Testing Market Growth Analysis | 2023-2028

    In-Vitro Toxicology Testing Market Growth Analysis | 2023-2028

    In-Vitro Toxicology Testing Market Growth Analysis | 2023-2028
    Report code - SR2522 Delivery - 2 Weeks
    In-Vitro Toxicology Testing Market Size, Share, Trends, Forecast, & Growth Analysis - See more...

    Market Insights

    The in-vitro toxicology testing market was estimated at USD 11.23 billion in 2022 and is likely to grow at a CAGR of 9.91% during 2023-2028 to reach USD 19.8 billion in 2028.

    In-Vitro-Toxicology-Testing-Market-Insights

    Want to know more about the market scope? Register Here

    What is in-vitro toxicity testing?

    In-vitro toxicity testing is referred to as the method of analyzing lethal or toxic chemical materials' effects either on cultured bacteria or mammalian cells. This testing method is performed to confirm the deficiency of several toxic properties at an early stage to develop novel substances such as food additives, agricultural chemicals, and therapeutic drugs and to identify potentially harmful chemicals.

    In-Vitro Toxicology Testing Market Report Highlights

    Market Size in 2022

    USD 11.23 billion

    Market Size in 2028

    USD 19.8 billion

    Market Growth (2023-2028)

    9.91% CAGR

    Base Year of Study

    2022

    Trend Period

    2017-2021

    Forecast Period

    2023-2028

    Market Dynamics

    The global in vitro toxicology testing market is growing at a positive growth during the study period. The market growth is attributed to the increase in a number of R&D procedures, the increase in awareness related to environmental concerns, ban on animal testing. Also, the emergence of novel approaches to 3D cell culture, and advancements in genetic screening approaches contribute to the overall market growth.

    However, the lack of skilled professionals in the industry hinders the overall market growth over the forecast period. The industry demands skilled professionals for troubleshooting activities, operation, validation, and method development. The testing process involves labor-intensive techniques such as making observations, analyzing data, collecting data, running tests of experiments, and many more.

    COVID-19 Impact

    The COVID-19 outbreak has affected the growth of the global in vitro toxicity testing industry majorly due to the strict lockdown measures across the globe resulting in manufacturing delays and the requirement of toxicity testing for various industry verticals such as the chemical industry, food & beverages industry, pharmaceutical industry, households sector and cosmetics industry.

    Due to the pandemic, various companies in the global in vitro toxicity testing industry to close down business operations to comply with government regulations across the globe to curb the spread of the disease. Operations closure directly impacted the revenue flow of the global in vitro toxicity testing industry. Lockdowns for several months and halt in industrial activities has affected the consistent growth of the global in vitro toxicity testing market and is anticipated to witness a slow recovery during the forecast period.

    In-Vitro-Toxicology-Testing-Market-Dynamics

    Want to have a closer look at this market report? Click Here.

    Segment Analysis

    By Type

    The market is further categorized into absorption, toxic substances, and dose. As per the detailed research study, the absorption segment is dominating the overall marketplace owing to the large-scale adoption of the in vitro toxicity testing market. Dose screening and toxic substances are some other segments in the global marketplace are anticipated to grow due to the rise in demand for in vitro toxicity testing in household products, cosmetics, chemicals, and pharmaceuticals.

    Also, the high efficiency of in vitro toxicity testing in diagnosis, the growth of global illicit drug abusers, and stringent government regulations to lessen cruelty while experimenting on animals, increase global illicit drug abusers, and enhanced efficiency of in vitro toxicity testing in diagnosis are some other driving factors of the market. However, incapability of IVTT to detect toxicities due to immune stimulation and autoimmunity and decrease in adoption rate of IVTT hamper the overall market growth.

    By Technology Type

    The global market is further categorized into cell culture technologies, high throughput technologies, and toxicogenomics. The cell culture technologies segment dominated the revenue share of the global marketplace in the base year 2022.

    By End User Type

    The market is sub-categorized into pharmaceuticals, cosmetics & household products, the chemicals industry, and food industry. The cosmetics and households products segment have the highest market share in the global marketplace of vitro toxicity testing in the year 2022.

    Regional Insights

    The regional segments of the global market are North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The North American in vitro toxicity testing market has the highest revenue growth, followed by Europe's in vitro toxicity testing market. On the other hand, the Asia-Pacific market is estimated to grow at a CAGR of 16% during the forecast period 2023-2028.

    In-Vitro-Toxicology-Testing-Market-Regional-Insights

    Know the high-growth countries in this report. Click Here

    Market Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The in vitro toxicity testing market is segmented into the following categories.

    By Type

    • Absorption
    • Toxic Substances
    • Dose

    By Technology Type

    • Cell Culture Technologies
    • High-Throughput Technologies
    • Cellular Imaging Technologies
    • Toxicogenomics

    By End-User Type

    • Pharmaceuticals
    • Cosmetics & household products
    • Chemicals industry
    • Food industry

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, the UK, Russia, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    In-Vitro-Toxicology-Testing-Market-Segmentation

    Click Here, to learn the market segmentation details.

    Key Players

    Major players in the global in vitro toxicity testing market, such as GlaxoSmithKline Plc (GSK), Agilent Technologies, General Electric Company, and some others are adopting various competitive strategies to maintain a strong foothold in the global marketplace. For instance, in January 2019, GlaxoSmithKline Plc acquired Tesaro Inc., an oncology-focused company based in Waltham, Massachusetts. This acquisition strengthened the pharmaceuticals business of GlaxoSmithkline. Moreover, in April 2019, Charles River Laboratories International acquired Citoxlab for around US$ 500 Mn. Such competitive strategies are estimated to offer lucrative opportunities for the market.

    Some of the major players operating in the market are:

    • Abbott
    • Agilent Technologies, Inc.
    • Beckman Coulter, Inc.
    • BioIVT
    • Bio-Rad Laboratories, Inc.
    • Catalent, Inc.
    • Charles River Laboratories International, Inc.
    • Dassault Systèmes
    • Eurofins Scientific
    • Evotec
    • General Electric Company
    • Gentronix
    • GlaxoSmithkline Plc
    • Labcorp Drug Development
    • MB Research Laboratories
    • Merck KGaA
    • Promega Corporation
    • QIAGEN
    • Quest Diagnostics Incorporated
    • SGS SA
    • Thermo Fisher Scientific Inc.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.

    We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the In-Vitro Toxicology Testing Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@Stratviewresearch.com.

     

    Frequently Asked Questions (FAQs)

    In-vitro toxicity testing is referred as the method of analyzing lethal or toxic chemical materials effects either on cultured bacteria or mammalian cells. This testing method is performed to confirm the deficiency of several toxic properties at early stage to develop novel substances such as food additives, agricultural chemical and therapeutic drugs and to indentify potentially harmful chemicals.

    The in-vitro toxicology testing market was estimated at USD 11.23 billion in 2022.

    The in-vitro toxicology testing market is likely to reach USD 19.8 billion in 2028.

    The in-vitro toxicology testing market is likely to grow at a CAGR of 9.91% during 2023-2028.

    Some of the major players operating in the market are Agilent Technologies, Inc., Abbott, Beckman Coulter, Inc., Merck KGaA, Dassault Systmes, General Electric Company, Quest Diagnostics Incorporated, Labcorp Drug Development, Thermo Fisher Scientific Inc., Catalent, Inc., Charles River Laboratories International, Inc., MB Research Laboratories, BioIVT, Gentronix, SGS SA, Eurofins Scientific, GlaxoSmithkline Plc, Bio-Rad Laboratories, Inc., QIAGEN, Promega Corporation, Evotec, Others.

    The North American in vitro toxicity testing market has the highest revenue growth, followed by Europe's market.

    The market growth is attributed to the increase in number of R&D procedures, increase in awareness related to environmental concerns, ban on animal testing. Also, emergence of novel approaches of 3D cell culture, advancements in genetic screening approaches also contribute in the overall market growth.

    The cell culture technologies segment dominated the revenue share of the global marketplace in the base year 2022.